Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126562962 | 12656296 | 2 | F | 20160812 | 20160812 | 20160816 | 20160819 | EXP | BR-BIOMARINAP-BR-2016-110729 | BIOMARIN | 9.52 | YR | M | Y | 0.00000 | 20160819 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126562962 | 12656296 | 1 | PS | VIMIZIM | ELOSULFASE ALFA | 1 | Intravenous (not otherwise specified) | UNK | NOT REPORTED | 125460 | SOLUTION FOR INFUSION | ||||||||
| 126562962 | 12656296 | 2 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126562962 | 12656296 | 1 | Mucopolysaccharidosis IV |
| 126562962 | 12656296 | 2 | Thrombosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126562962 | 12656296 | HO |
| 126562962 | 12656296 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126562962 | 12656296 | Coma | |
| 126562962 | 12656296 | Death | |
| 126562962 | 12656296 | Haemorrhage | |
| 126562962 | 12656296 | Nosocomial infection | |
| 126562962 | 12656296 | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126562962 | 12656296 | 1 | 20141016 | 0 |